These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

78 related articles for article (PubMed ID: 2009268)

  • 1. Synthesis and structure-activity study of myxoma virus growth factor.
    Lin YZ; Ke XH; Tam JP
    Biochemistry; 1991 Apr; 30(13):3310-4. PubMed ID: 2009268
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Growth inhibition by vaccinia virus growth factor.
    Lin YZ; Ke XH; Tam JP
    J Biol Chem; 1990 Nov; 265(31):18884-90. PubMed ID: 2229050
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synthesis of a biological active tumor growth factor from the predicted DNA sequence of Shope fibroma virus.
    Lin YZ; Caporaso G; Chang PY; Ke XH; Tam JP
    Biochemistry; 1988 Jul; 27(15):5640-5. PubMed ID: 2846046
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synthesis of biologically active transforming growth factor alpha.
    Tam JP
    Int J Pept Protein Res; 1987 Mar; 29(3):421-31. PubMed ID: 3474216
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chemical synthesis and biological activities of the EGF-like domain of mouse schwannoma-derived growth factor (SDGF).
    Takenouchi T; Kadosaka M; Shin SY; Munekata E
    Int J Pept Protein Res; 1995 Nov; 46(5):391-6. PubMed ID: 8567183
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synthesis and properties of cholecystokinin-releasing peptide (monitor peptide), a 61-residue trypsin inhibitor.
    Lin YZ; Isaac DD; Tam JP
    Int J Pept Protein Res; 1990 Nov; 36(5):433-9. PubMed ID: 2276871
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Transforming growth factor alpha, Shope fibroma growth factor, and vaccinia growth factor can replace myxoma growth factor in the induction of myxomatosis in rabbits.
    Opgenorth A; Nation N; Graham K; McFadden G
    Virology; 1993 Feb; 192(2):701-9. PubMed ID: 8380671
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Deletion analysis of two tandemly arranged virulence genes in myxoma virus, M11L and myxoma growth factor.
    Opgenorth A; Graham K; Nation N; Strayer D; McFadden G
    J Virol; 1992 Aug; 66(8):4720-31. PubMed ID: 1629952
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Growth factor from human milk: purification and characterization.
    Kanda Y; Yamamoto N; Abe Y
    Life Sci; 1994; 55(19):1509-20. PubMed ID: 7968218
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Assessment of biological activity of synthetic fragments of transforming growth factor alpha.
    Schultz G; Twardzik D
    Methods Enzymol; 1991; 198():200-13. PubMed ID: 1857219
    [No Abstract]   [Full Text] [Related]  

  • 11. Chemical synthesis, structural modeling, and biological activity of the epidermal growth factor-like domain of human cripto.
    Lohmeyer M; Harrison PM; Kannan S; DeSantis M; O'Reilly NJ; Sternberg MJ; Salomon DS; Gullick WJ
    Biochemistry; 1997 Apr; 36(13):3837-45. PubMed ID: 9092813
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Biochemical properties of site-directed mutants of human epidermal growth factor: importance of solvent-exposed hydrophobic residues of the amino-terminal domain in receptor binding.
    Campion SR; Matsunami RK; Engler DA; Niyogi SK
    Biochemistry; 1990 Oct; 29(42):9988-93. PubMed ID: 2271634
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Epidermal growth factor-like growth factors. I. Breast malignancies and other epithelial proliferations in transgenic mice.
    Strayer DS; Yang S; Schwartz MS
    Lab Invest; 1993 Dec; 69(6):660-73. PubMed ID: 8264229
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Modulation of the receptor binding affinity of amphiregulin by modification of its carboxyl terminal tail.
    Adam R; Drummond DR; Solic N; Holt SJ; Sharma RP; Chamberlin SG; Davies DE
    Biochim Biophys Acta; 1995 Apr; 1266(1):83-90. PubMed ID: 7718625
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A synthetic approach to structure-function relationships in the murine epidermal growth factor molecule.
    Heath WF; Merrifield RB
    Proc Natl Acad Sci U S A; 1986 Sep; 83(17):6367-71. PubMed ID: 3018729
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synthesis and biological activity of N-terminal-truncated derivatives of human epidermal growth factor (h-EGF).
    Shin SY; Shimizu M; Ohtaki T; Munekata E
    Peptides; 1995; 16(2):205-10. PubMed ID: 7784250
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Alteration of the kinetic properties of the epidermal growth factor receptor tyrosine kinase by basic proteins.
    Hubler L; Leventhal PS; Bertics PJ
    Biochem J; 1992 Jan; 281 ( Pt 1)(Pt 1):107-14. PubMed ID: 1370607
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differential effects of epidermal growth factor, somatomedin-C/insulin-like growth factor I, and transforming growth factor-beta on porcine granulosa cell deoxyribonucleic acid synthesis and cell proliferation.
    May JV; Frost JP; Schomberg DW
    Endocrinology; 1988 Jul; 123(1):168-79. PubMed ID: 3260173
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Structure-activity relationships of human epidermal growth factor(h-EGF).
    Shin SY; Watanabe M; Kako K; Ohtaki T; Munekata E
    Life Sci; 1994; 55(2):131-9. PubMed ID: 8015356
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Autocrine action of amphiregulin in a colon carcinoma cell line and immunocytochemical localization of amphiregulin in human colon.
    Johnson GR; Saeki T; Gordon AW; Shoyab M; Salomon DS; Stromberg K
    J Cell Biol; 1992 Aug; 118(3):741-51. PubMed ID: 1639855
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.